Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2021

Nov 25, 2021

60507_rns_2021-11-25_afad6efc-0203-4768-a8aa-feaf457c54e3.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 42] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

November 25, 2021

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1st Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Dalal Street, Fort Plot No. C/1, G Block Mumbai – 400 001 Bandra-Kurla Complex, Bandra (E) Scrip Code: 500680 Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation regarding loss of share certificates and issue of duplicate share

certificates

Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificate(s) from the below Shareholder(s):

below Shareholder(s):
Sr.
No.
Name Folio No. Certificate
No.
Number
of Shares
Dist Nos.
From
Dist Nos.
To
1. Ms. Pratibha Gupta P 0144313 398326 11 29100479 29100489

We shall issue the duplicate Share Certificate(s) upon completion of necessary formalities by the shareholder(s).

Please take the above on record.

Thanking you,

Yours truly,

For Pfizer Limited

==> picture [102 x 39] intentionally omitted <==

Prajeet Nair Company Secretary

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerindia.com